Prescriber Update is a quarterly medical safety publication issued by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. It is intended for healthcare professionals to communicate emerging safety signals, drug risks, regulatory updates, and clinical advice.
This document is an official publication from the European Medicines Agency (EMA) detailing the safety recommendations made by its Pharmacovigilance Risk Assessment Committee (PRAC) following its meeting from 27–30 October 2025. It outlines newly identified safety "signals" (potential risks) associated with specific medicines and the regulatory actions required.
Lock therapy (also called catheter lock therapy or antibiotic lock therapy - ALT) refers to a technique where a high-concentration antimicrobial or anticoagulant solution is instilled into the lumen of an indwelling vascular access device (like a central venous catheter, port, or cannula) and allowing it to dwell for a specified period when the catheter is not in active use.
This is a critical and profound topic. Let's illustrate the difference between equality and equity in patient safety with detailed, healthcare-specific examples.
This document is the Report of the CIOMS Working Group XIV on Artificial Intelligence in Pharmacovigilance. It addresses the rapidly emerging and cross-disciplinary field of integrating Artificial Intelligence (AI) into Pharmacovigilance (PV).
This document is the official strategy published by the World Health Organization (WHO) to provide a practical and adaptable framework for countries, particularly Low- and Middle-Income Countries (LMICs), to build, strengthen, and sustain their Pharmacovigilance (PV) systems for medicines and vaccines.
This document is the October 2025 newsletter (Volume 19, Issue 10) from the Egyptian Pharmacovigilance Center (EPVC). It is a detailed bulletin focused on drug safety monitoring and public health in Egypt.
Advancing Medication Safety Through Knowledge and Vigilance
